医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
1-甲基吲哚-2-甲醛 | 1-methyl-1H-indole-2-carboxaldehyde | 27421-51-8 | C10H9NO |
|
1-甲基吲哚-2-甲酸 | N-methyl-1H-indole-2-carboxylic acid | 16136-58-6 | C10H9NO2 |
|
1-甲基吡唑[3,4B]并吡啶-3-甲酸 | 1-methylpyrazolo<3,4-b>pyridine-3-carboxylic acid | 116855-09-5 | C8H7N3O2 |
|
1-甲基吡唑-4-羧酸乙酯 | ethyl 1-methylpyrazole-4-carboxylate | 85290-80-8 | C7H10N2O2 |
|
1-甲基吡唑-4-羧酸 | 1-methyl-1H-pyrazole-4-carboxylic acid | 5952-92-1 | C5H6N2O2 |
|
1-甲基吡唑-3-基-硼酸频哪醇酯 | 1-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole | 1020174-04-2 | C10H17BN2O2 |
|
1-甲基吡唑 | 1-methyl-1H-pyrazole | 930-36-9 | C4H6N2 |
|
1-甲基吡咯烷 | 1-Methylpyrrolidine | 120-94-5 | C5H11N |
|
1-甲基-L-4,5-二氢乳清酸 | (S)-3-methyldihydroorotic acid | 103365-69-1 | C6H8N2O4 |
|
1-甲基-7-硝基-1,2,3,4-四氢喹啉 | 1-methyl-7-nitro-1,2,3,4-tetrahydro-quinoline | 39275-18-8 | C10H12N2O2 |
|
1-甲基-7-甲氧基异喹啉 | 7-methoxy-1-methylisoquinoline | 76143-84-5 | C11H11NO |
|
1-甲基-7-氮杂吲哚 | 1-methyl-1H-pyrrolo[2,3-b]pyridine | 27257-15-4 | C8H8N2 |
|
1-甲基-6-甲氧基异羟基喹啉 | 6-methoxy-1-methyl-2H-isoquinolin-1-ol | 140683-35-8 | C11H13NO2 |
|
1-甲基-6-氧代-1,6-二氢哒嗪-3-甲酸 | 1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxylic acid | 100047-66-3 | C6H6N2O3 |
|
1-甲基-6-氧代-1,6-二氢吡啶-3-羧酸 | 1-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid | 3719-45-7 | C7H7NO3 |
|
1-甲基-6,7-二甲氧基-3,4-二氢异喹啉 | 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline | 4721-98-6 | C12H15NO2 |
|
1-甲基-5-硝基吲哚-2-羧酸 | 1-methyl-5-nitro-1H-indol-2-carboxylic acid | 71056-94-5 | C10H8N2O4 |
|
1-甲基-5-硝基-2(1H)-吡啶酮 | 1-methyl-5-nitro-2(1H)-pyridone | 32896-90-5 | C6H6N2O3 |
|
1-甲基-5-硝基-1H-吲哚 | 1-methyl-5-nitro-1H-indole | 29906-67-0 | C9H8N2O2 |
|
1-甲基-5-氨基吡唑 | 5-Amino-1-methylpyrazole | 1192-21-8 | C4H7N3 |
|
1-甲基-5-乙酰基吡唑 | 1-(1-methyl-1H-pyrazol-5-yl)ethan-1-one | 137890-05-2 | C6H8N2O |
|
1-甲基-4-苯基-1,2,3,6-四氢吡啶盐酸盐 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride | 23007-85-4 | C12H15N*ClH |
|
1-甲基-4-苯基-1,2,3,6-四氢吡啶 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 28289-54-5 | C12H15N |
|
1-甲基-4-羧酸-5-(3-吡啶)-2-吡咯烷酮 | (2S,3S)-1-methyl-5-oxo-2-(pyridin-3-yl)pyrrolidine-3-carboxylic acid | 33224-01-0 | C11H12N2O3 |
|
1-甲基-4-硝基咪唑-2-羧酸乙酯 | ethyl 1-methyl-4-nitroimidazole-2-carboxylate | 109012-23-9 | C7H9N3O4 |
|
1-甲基-4-硝基吡唑 | 1-methyl-4-nitropyrazole | 3994-50-1 | C4H5N3O2 |
|
1-甲基-4-硝基-2-(叔丁基)-1H-咪唑 | tert-butyl 4-nitro-1-methylimidazole-2-carboxylate | 179983-49-4 | C9H13N3O4 |
|
1-甲基-4-氯吡唑并[3,4-d]嘧啶 | 4-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine | 23000-43-3 | C6H5ClN4 |
|
1-甲基-4-哌啶甲酸甲酯 | 1-methyl-piperidine-4-carboxylic acid methyl ester | 1690-75-1 | C8H15NO2 |
|
1-甲基-4-哌啶甲酸乙酯 | ethyl 1-methylisonipecotate | 24252-37-7 | C9H17NO2 |
|
1-甲基-4-咪唑甲酸 | 1-methylimidazole-4-carboxylic acid | 41716-18-1 | C5H6N2O2 |
|
1-甲基-4-亚硝基哌嗪 | 1-methyl-4-nitroso-piperazine | 16339-07-4 | C5H11N3O |
|
1-甲基-4-[4-(4-甲基-1,3,2-二氧杂硼硼烷-2-基)-1H-吡唑-1-基]哌啶 | 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine | 1323919-64-7 | C15H26BN3O2 |
|
1-甲基-4-(羟基乙基)哌啶 | 2-(1-methyl-4-piperidyl)ethanol | 21156-84-3 | C8H17NO |
|
1-甲基-4-(甲氨基)哌啶 | Methyl-(1-methyl-[4]piperidyl)-amin | 73579-08-5 | C7H16N2 |
|
1-甲基-4-(哌啶-4-基)哌嗪盐酸盐 | 1-methyl-4-(piperidin-4-yl)piperazine hydrochloride | 436099-90-0 | C10H21N3*ClH |
|
1-甲基-4-(6-硝基吡啶-3-基)哌嗪 | 1-methyl-4-(6-nitropyridin-3-yl)piperazine | 657410-79-2 | C10H14N4O2 |
|
1-甲基-4-(6-氨基吡啶-3-基)哌嗪 | 5-(4-methyl-piperazin-1-yl)pyridin-2-ylamine | 571189-49-6 | C10H16N4 |
|
1-甲基-4-(4-硝基苯基)哌嗪 | 1-methyl-4-(4-nitrophenyl)piperazine | 16155-03-6 | C11H15N3O2 |
|
1-甲基-4-(4-哌啶基)哌嗪 | 1-methyl-4-(piperidin-4-yl)piperazine | 53617-36-0 | C10H21N3 |
|
1-甲基-4,5,6,7-四氢-1H-吡唑并[3,4-c]吡啶双盐酸盐 | 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine dihydrochloride | 1228878-69-0 | C7H13Cl2N3 |
|
1-甲基-3-(3-氧代环己烯-1-基)氮杂卓-2-酮 | hexahydro-1-methyl-3-(3-oxocyclohexen-1-yl)<2H>azepin-2-one | 71556-70-2 | C13H19NO2 |
|
1-甲基-3-苯基哌嗪 | 1-methyl-3-phenylpiperazine | 5271-27-2 | C11H16N2 |
|
1-甲基-3-硝基吲哚 | 1-methyl-3-nitroindole | 36728-89-9 | C9H8N2O2 |
|
1-甲基-3-硝基吡啶-2-酮 | 1-methyl-3-nitropyridin-2(1H)-one | 32896-91-6 | C6H6N2O3 |
|
1-甲基-3-氨基-5-碘吡啶并咪唑 | 1-methyl-3-amino-5-iodo-1H-pyrazolo[3,4-b]pyridine | 766515-35-9 | C7H7IN4 |
|
1-甲基-3-氧代哌嗪 | 4-methylpiperazin-2-one | 34770-60-0 | C5H10N2O |
|
1-甲基-3-吡咯烷羧酸 | 1-methylpyrrolidine-3-carboxylic acid | 25712-60-1 | C6H11NO2 |
|
1-甲基-3-丙基-1H-吡唑-5-甲酸 | 1-methyl-3-propyl-1 H-pyrazole-5-carboxylic acid | 139755-99-0 | C8H12N2O2 |
|
1-甲基-3-三氟甲基-1H-吡唑 | 1-methyl-3-(trifluoromethyl)-1H-pyrazole | 154471-65-5 | C5H5F3N2 |
|